These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 9512682

  • 1. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K, Saitoh S, Kumada H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
    [Abstract] [Full Text] [Related]

  • 2. Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.
    Ikeda K, Saitoh S, Suzuki Y, Tsubota A, Koida I, Kobayashi M, Arase Y, Chayama K, Murashima N, Kumada H.
    J Gastroenterol; 1997 Aug; 32(4):513-20. PubMed ID: 9250900
    [Abstract] [Full Text] [Related]

  • 3. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [Abstract] [Full Text] [Related]

  • 4. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K, Obuchi M, Honda M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [Abstract] [Full Text] [Related]

  • 5. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J, Hyodo I, Tanimizu M, Tanada M, Nishikawa Y, Hosokawa Y, Mandai K, Moriwaki S.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [Abstract] [Full Text] [Related]

  • 6. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T, Tabaru K, Isogai M, Nagamitsu A, Oda T.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y, Nakamura H.
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
    Miura K, Nakao N, Yoshimoto A, Yamano T, Inoue J, Takayasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A case of hepatocellular carcinoma with tumor thrombus in the right atrium successfully treated by arterial administration of lipiodol-SMANCS].
    Yamada K, Sato T, Yamada A, Tanaka S, Fujii S, Matuo R, Murata K, Manabe T, Oda J.
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):361-4. PubMed ID: 10065101
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.